Cour Pharmaceuticals

COUR Pharmaceuticals is developing first-class therapies aimed at reprogramming the immune system to achieve antigen-specific tolerance for immune-mediated diseases. COUR’s immune-modifying nanoparticle platform treats the root cause of immune diseases, which is different from traditional methods that only use toxic immunosuppression to minimize symptoms.